It is important for pediatricians to understand how TFTs are affected by obesity, when to order thyroid function tests, and when to refer.
Read More
Thyroid hormone replacement is a critical element in the overall management of patients with thyroid cancer.
Thyroid cancer in pediatric patients is not a rare entity, in fact it is the most common non-CNS solid tumor in childhood.
Familial non-medullary thyroid cancer (FNMTC) constitutes 3–9% of all thyroid cancer cases and is divided into syndromic and non-syndromic FNMTC.
After receiving a diagnosis of papillary thyroid cancer, intuitively, the thought has been that surgery is the next step. While this was the standard in the past, we now know that in specific situations immediate surgery may not be necessary.
Thyroid Health Blog: Congenital Hypothyroidism awareness: The importance of newborn screening
Thyroid Health Blog: Keeping an Eye Out for Thyroid Eye Disease
Thyroid Health Blog: Expanding Medical Therapies for Medullary Thyroid Cancer
Thyroid Health Blog: An approach to the patient with thyroid disease and high symptom burden
Thyroid Health Blog: Is Prescription Levothyroxine really an artificial hormone?
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.